Pablo Ramirez, MD

Dr. Pablo Ramirez received his M.D. (Human Medicine) from the Universidad Austral, Chile in 1997.  His residency in Internal Medicine was conducted at P. Universidad Catolica, Chile.  He followed this with a fellowship in Hematology-Oncology at the same institution.  In 2006 Dr. Ramirez began advanced training in an accredited Clinical Training Program in Malignant Hematology (mentor: Dr. John F. DiPersio) at Washington University in St. Louis, Missouri.  During this time he also worked in Dr. DiPersio’s lab on a project related to the role of CXCR4 and VLA-4 on stem and leukemia cell homing and egress using a novel acute promyelocytic leukemia murine model and an in vitro model with murine mesenchymal stromal cells.  Dr. Ramirez entered the fellowship program in Hematology, Oncology and Transplantation at the University of Minnesota in 2009.

Publications

Yulis CR, Mota MD, Andrades JA, Rodriguez S, Peruzzo B, Mancera JM, Ramirez P, Garrido M, Perez-Figarez JM, Fernandez-Liebrez P, Rodriguez EM.  The floor plate and the subcommissural organ are the source of secretory compounds of related nature: Comparative immunocytochemical study.  J Comp Neurol 1998; 392:19-34.

Perez JA, Poblete MT, Castillo P, Ramirez P, de Sousa U, Perez A.  Merkel cell carcinoma.  Report on 4 cases.  Rev Med Chil 1998; 126:553-558.

Ardiles L, Ramirez P, Calderon S, Aguirre V, Poblete MT.  Life-threatening hypokalemic paralysis and hypophosphatemic myopathy as initial presentations of primary Sjogren’s Syndrome.  J Clin Rheumatol 2001; 7:410-411.

Presentations

Nervi B, Ramirez P, Holt M, Rettig MP, Ritchey JK, Prior JL, Piwnica-Worms D, Bridger G, Ley TJ, DiPersio JF.  CXCR4/SDF-1 is a key regulator for leukemia migration and homing to the bone marrow: Impact of AMD3100 on in vivo response to chemotherapy.  (Simultaneous session: Acute Promyelocytic Leukemias and Novel Approaches to AML).  Poster presented at the American Society of Hematology meeting; Orlando FL; December 2006.